Sun Pharma Appoints Kirti Ganorkar as MD:
Sun Pharmaceutical Industries Ltd, India’s largest pharmaceutical company, has appointed Kirti Ganorkar as its Managing Director, effective September 1, 2025. The move marks the culmination of a carefully planned succession process, with founder Dilip Shanghvi transitioning to the role of Executive Chairman. While Ganorkar will oversee day-to-day business operations, Shanghvi will continue guiding the company’s long-term strategy and its specialty portfolio.Sun Pharma announced a significant leadership change aimed at reinforcing its long-term growth trajectory. Kirti Ganorkar’s elevation as MD and Dilip Shanghvi’s continued role as Executive Chairman underscore a strategic shift aligned with governance continuity, innovation, and global expansion. The announcement follows steady growth in Sun Pharma’s India business and reflects confidence in internal leadership development.
